ETHYL 5-HYDROXYPYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXYLATE, 97.0%, 250mg

2-((4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)methyl)benzonitrile, 1g

6-Methoxy-4-(trifluoromethyl)pyridin-2-amine, 95.0%, 5g

4-METHYL-6-NITRO-2-(PYRROLIDIN-1-YL)QUINOLINE, 95.0%, 100mg

2-Bromo-1-(4-bromo-2-fluorophenyl)ethanone, 95.0%, 250mg

1H-Pyrrolo[3,2-b]pyridin-3-amine, 98%, 250mg

4-Bromo-1-methyl-1H-indole, 95.0%, 1g

Plan PLMi 5x/0.12 infinity corrected IOS objective. Working distance 26.1 mm

N-METHYLPYRIDINE-2-CARBOXAMIDE, 95%, 2.5g

(R)-1-N-Boc-3-Cyanopiperazine, 95.0%, 5g

AMMONIUM DODECYL SULFATE, 95%, 25g

4,4-dimethyl-1-pentanol, 95.0%, 1g

Ethyl 3-oxo-3-(tetrahydro-2H-pyran-4-yl)propanoate, 95.0%, 10g